As of 3:59pm ET
| +0.73 / +12.05%|
The 7 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 10.00, with a high estimate of 16.00 and a low estimate of 3.00. The median estimate represents a +47.28% increase from the last price of 6.79.
The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.